| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 41 | 2021 | 1506 | 5.230 |
Why?
|
| Blood Vessel Prosthesis Implantation | 31 | 2023 | 1456 | 4.340 |
Why?
|
| Aortic Aneurysm, Abdominal | 18 | 2022 | 1250 | 3.550 |
Why?
|
| Lower Extremity | 24 | 2017 | 1217 | 2.430 |
Why?
|
| Ischemia | 25 | 2024 | 1905 | 2.380 |
Why?
|
| Peripheral Arterial Disease | 24 | 2024 | 1304 | 2.340 |
Why?
|
| Arterial Occlusive Diseases | 13 | 2019 | 743 | 2.290 |
Why?
|
| Endovascular Procedures | 19 | 2024 | 2215 | 2.140 |
Why?
|
| Limb Salvage | 20 | 2024 | 488 | 2.130 |
Why?
|
| Popliteal Artery | 12 | 2022 | 313 | 1.920 |
Why?
|
| Vascular Patency | 34 | 2023 | 915 | 1.820 |
Why?
|
| Blood Vessel Prosthesis | 14 | 2023 | 956 | 1.800 |
Why?
|
| Graft Occlusion, Vascular | 16 | 2024 | 538 | 1.610 |
Why?
|
| Femoral Artery | 14 | 2022 | 827 | 1.600 |
Why?
|
| Stents | 14 | 2020 | 3193 | 1.590 |
Why?
|
| Endarterectomy, Carotid | 8 | 2018 | 556 | 1.510 |
Why?
|
| Angioplasty, Balloon | 4 | 2022 | 592 | 1.190 |
Why?
|
| Iliac Artery | 3 | 2019 | 344 | 1.190 |
Why?
|
| Saphenous Vein | 10 | 2024 | 519 | 1.170 |
Why?
|
| Arteriovenous Shunt, Surgical | 9 | 2023 | 291 | 1.080 |
Why?
|
| Carotid Stenosis | 7 | 2018 | 858 | 1.010 |
Why?
|
| Leg | 9 | 2013 | 1087 | 0.970 |
Why?
|
| Veins | 15 | 2017 | 769 | 0.920 |
Why?
|
| Endoleak | 4 | 2017 | 111 | 0.890 |
Why?
|
| Peripheral Vascular Diseases | 9 | 2011 | 488 | 0.850 |
Why?
|
| Aortic Diseases | 5 | 2018 | 741 | 0.850 |
Why?
|
| Intermittent Claudication | 6 | 2016 | 305 | 0.810 |
Why?
|
| Lithotripsy | 1 | 2023 | 137 | 0.810 |
Why?
|
| Treatment Outcome | 75 | 2023 | 65295 | 0.760 |
Why?
|
| Reoperation | 20 | 2023 | 4325 | 0.750 |
Why?
|
| Time Factors | 53 | 2023 | 40154 | 0.750 |
Why?
|
| Subclavian Artery | 2 | 2019 | 138 | 0.740 |
Why?
|
| Trabeculectomy | 3 | 2017 | 174 | 0.660 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 148 | 0.630 |
Why?
|
| Device Removal | 3 | 2021 | 643 | 0.620 |
Why?
|
| Carotid Body Tumor | 1 | 2018 | 34 | 0.600 |
Why?
|
| Carotid Artery Diseases | 3 | 2014 | 872 | 0.580 |
Why?
|
| Gonioscopy | 2 | 2017 | 157 | 0.560 |
Why?
|
| Vascular Fistula | 2 | 2020 | 50 | 0.540 |
Why?
|
| Dissection | 1 | 2018 | 298 | 0.540 |
Why?
|
| Patient Readmission | 5 | 2014 | 3283 | 0.530 |
Why?
|
| Exfoliation Syndrome | 1 | 2017 | 113 | 0.510 |
Why?
|
| Intestinal Fistula | 2 | 2020 | 146 | 0.510 |
Why?
|
| Postoperative Complications | 22 | 2022 | 15824 | 0.510 |
Why?
|
| Sclera | 1 | 2017 | 189 | 0.500 |
Why?
|
| Intraoperative Care | 1 | 2019 | 768 | 0.500 |
Why?
|
| Inguinal Canal | 3 | 2005 | 71 | 0.500 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 1403 | 0.490 |
Why?
|
| Models, Economic | 4 | 2016 | 719 | 0.490 |
Why?
|
| Aortography | 6 | 2018 | 423 | 0.480 |
Why?
|
| Aged | 89 | 2024 | 171319 | 0.480 |
Why?
|
| Laser Therapy | 3 | 2017 | 1108 | 0.460 |
Why?
|
| Renal Dialysis | 8 | 2023 | 1790 | 0.450 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2015 | 707 | 0.450 |
Why?
|
| Retrospective Studies | 54 | 2024 | 81659 | 0.440 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 640 | 0.440 |
Why?
|
| Foot Ulcer | 1 | 2014 | 62 | 0.440 |
Why?
|
| Health Care Costs | 5 | 2016 | 3239 | 0.430 |
Why?
|
| Emergencies | 1 | 2019 | 1223 | 0.420 |
Why?
|
| Aorta | 3 | 2021 | 2045 | 0.410 |
Why?
|
| Risk Factors | 45 | 2024 | 74886 | 0.410 |
Why?
|
| Kaplan-Meier Estimate | 14 | 2017 | 6513 | 0.410 |
Why?
|
| Radial Artery | 4 | 2022 | 187 | 0.400 |
Why?
|
| Length of Stay | 8 | 2021 | 6489 | 0.400 |
Why?
|
| Risk Assessment | 28 | 2023 | 24299 | 0.400 |
Why?
|
| Iliac Aneurysm | 1 | 2012 | 37 | 0.390 |
Why?
|
| Male | 99 | 2024 | 364203 | 0.380 |
Why?
|
| Aged, 80 and over | 38 | 2024 | 59548 | 0.380 |
Why?
|
| Hospital Costs | 2 | 2014 | 956 | 0.360 |
Why?
|
| Humans | 130 | 2024 | 767040 | 0.350 |
Why?
|
| Prosthesis-Related Infections | 3 | 2022 | 497 | 0.350 |
Why?
|
| Multivariate Analysis | 18 | 2017 | 12069 | 0.350 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2017 | 742 | 0.350 |
Why?
|
| Visual Acuity | 4 | 2017 | 2714 | 0.340 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 391 | 0.340 |
Why?
|
| Middle Aged | 67 | 2024 | 223233 | 0.340 |
Why?
|
| Foot | 1 | 2014 | 576 | 0.340 |
Why?
|
| Female | 92 | 2024 | 396660 | 0.330 |
Why?
|
| Angioplasty | 3 | 2021 | 355 | 0.330 |
Why?
|
| Workload | 2 | 2020 | 849 | 0.330 |
Why?
|
| Aneurysm | 2 | 2010 | 343 | 0.320 |
Why?
|
| Ultrasonography, Doppler, Duplex | 8 | 2024 | 198 | 0.320 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 2420 | 0.320 |
Why?
|
| Patient Selection | 10 | 2018 | 4256 | 0.320 |
Why?
|
| Vision Disorders | 1 | 2016 | 1090 | 0.300 |
Why?
|
| Venous Thrombosis | 2 | 2009 | 1321 | 0.300 |
Why?
|
| Proportional Hazards Models | 15 | 2017 | 12536 | 0.300 |
Why?
|
| Chi-Square Distribution | 9 | 2017 | 3431 | 0.300 |
Why?
|
| Markov Chains | 5 | 2016 | 976 | 0.300 |
Why?
|
| Prosthesis Design | 7 | 2023 | 2120 | 0.300 |
Why?
|
| Polytetrafluoroethylene | 2 | 2023 | 242 | 0.290 |
Why?
|
| Wound Healing | 10 | 2017 | 2800 | 0.280 |
Why?
|
| Registries | 11 | 2021 | 8351 | 0.280 |
Why?
|
| Laser Coagulation | 4 | 2012 | 335 | 0.270 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3618 | 0.260 |
Why?
|
| Kidney Failure, Chronic | 2 | 2021 | 2495 | 0.260 |
Why?
|
| Retreatment | 4 | 2017 | 598 | 0.260 |
Why?
|
| Vascular Grafting | 4 | 2024 | 163 | 0.260 |
Why?
|
| Renal Veins | 1 | 2006 | 103 | 0.260 |
Why?
|
| Arteriovenous Fistula | 2 | 2022 | 320 | 0.250 |
Why?
|
| Databases, Factual | 6 | 2023 | 8068 | 0.250 |
Why?
|
| Arteries | 3 | 2013 | 1123 | 0.250 |
Why?
|
| Robotics | 1 | 2012 | 807 | 0.240 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 1208 | 0.240 |
Why?
|
| Congresses as Topic | 1 | 2009 | 812 | 0.230 |
Why?
|
| Iliac Vein | 1 | 2004 | 71 | 0.230 |
Why?
|
| Aneurysm, Ruptured | 1 | 2009 | 455 | 0.230 |
Why?
|
| Hematoma | 3 | 2017 | 766 | 0.230 |
Why?
|
| Renal Insufficiency | 2 | 2013 | 812 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 996 | 0.220 |
Why?
|
| Surgical Wound Infection | 5 | 2017 | 1547 | 0.220 |
Why?
|
| Intraocular Pressure | 3 | 2017 | 1304 | 0.220 |
Why?
|
| Viscera | 1 | 2004 | 138 | 0.220 |
Why?
|
| Follow-Up Studies | 21 | 2022 | 39317 | 0.210 |
Why?
|
| Odds Ratio | 11 | 2017 | 9660 | 0.210 |
Why?
|
| Visually Impaired Persons | 2 | 2016 | 79 | 0.210 |
Why?
|
| American Heart Association | 4 | 2011 | 1049 | 0.210 |
Why?
|
| Vena Cava, Inferior | 1 | 2006 | 463 | 0.210 |
Why?
|
| Critical Illness | 7 | 2016 | 2753 | 0.210 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2174 | 0.210 |
Why?
|
| Recovery of Function | 7 | 2019 | 2978 | 0.200 |
Why?
|
| Atherectomy | 1 | 2022 | 41 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 7 | 2016 | 5537 | 0.200 |
Why?
|
| Groin | 3 | 2013 | 106 | 0.200 |
Why?
|
| Advisory Committees | 3 | 2011 | 797 | 0.200 |
Why?
|
| Carotid Arteries | 3 | 2023 | 934 | 0.200 |
Why?
|
| Clinical Competence | 3 | 2020 | 4859 | 0.200 |
Why?
|
| Retinal Diseases | 4 | 2012 | 709 | 0.200 |
Why?
|
| United States | 26 | 2024 | 72971 | 0.190 |
Why?
|
| Cognition Disorders | 1 | 2016 | 3968 | 0.190 |
Why?
|
| Age Factors | 7 | 2019 | 18401 | 0.190 |
Why?
|
| Boston | 11 | 2021 | 9360 | 0.190 |
Why?
|
| Wrist | 2 | 2021 | 231 | 0.180 |
Why?
|
| Electroporation | 2 | 2013 | 238 | 0.180 |
Why?
|
| Forearm | 1 | 2023 | 427 | 0.170 |
Why?
|
| Glaucoma, Angle-Closure | 2 | 2015 | 192 | 0.170 |
Why?
|
| Amblyopia | 1 | 2022 | 152 | 0.170 |
Why?
|
| Brachial Artery | 2 | 2023 | 373 | 0.170 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2013 | 263 | 0.170 |
Why?
|
| Video Games | 1 | 2022 | 202 | 0.170 |
Why?
|
| Laparoscopy | 1 | 2012 | 2037 | 0.170 |
Why?
|
| Retina | 6 | 2013 | 2659 | 0.170 |
Why?
|
| Comorbidity | 10 | 2019 | 10582 | 0.170 |
Why?
|
| Severity of Illness Index | 11 | 2019 | 15925 | 0.170 |
Why?
|
| Prospective Studies | 23 | 2022 | 54886 | 0.170 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 2054 | 0.170 |
Why?
|
| Transplantation, Autologous | 8 | 2009 | 2118 | 0.170 |
Why?
|
| Angiography | 4 | 2016 | 1597 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 1523 | 0.160 |
Why?
|
| Eye Injuries | 2 | 2012 | 228 | 0.150 |
Why?
|
| Trabecular Meshwork | 2 | 2017 | 101 | 0.150 |
Why?
|
| Deglutition | 1 | 2019 | 208 | 0.150 |
Why?
|
| Cognition | 1 | 2016 | 7059 | 0.150 |
Why?
|
| Certification | 2 | 2014 | 420 | 0.150 |
Why?
|
| Databases as Topic | 2 | 2011 | 472 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2009 | 1882 | 0.140 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 331 | 0.140 |
Why?
|
| Ocular Hypotension | 1 | 2017 | 23 | 0.140 |
Why?
|
| Israel | 2 | 2017 | 726 | 0.140 |
Why?
|
| Seroma | 1 | 2017 | 75 | 0.140 |
Why?
|
| Aging | 1 | 2016 | 8729 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2015 | 2765 | 0.130 |
Why?
|
| Tonometry, Ocular | 1 | 2017 | 238 | 0.130 |
Why?
|
| Renal Artery | 2 | 2010 | 355 | 0.130 |
Why?
|
| Polymers | 1 | 2023 | 1624 | 0.130 |
Why?
|
| Neuroprotective Agents | 3 | 2012 | 956 | 0.130 |
Why?
|
| Anastomosis, Surgical | 2 | 2012 | 992 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 705 | 0.120 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2016 | 153 | 0.120 |
Why?
|
| Cloprostenol | 1 | 2015 | 21 | 0.120 |
Why?
|
| Aorta, Abdominal | 2 | 2017 | 627 | 0.120 |
Why?
|
| Cause of Death | 2 | 2012 | 3717 | 0.120 |
Why?
|
| Health Resources | 3 | 2013 | 948 | 0.120 |
Why?
|
| Aneurysm, False | 2 | 2017 | 263 | 0.120 |
Why?
|
| Frail Elderly | 1 | 2020 | 781 | 0.120 |
Why?
|
| Silver Compounds | 1 | 2014 | 24 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 636 | 0.120 |
Why?
|
| Logistic Models | 6 | 2017 | 13284 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2016 | 504 | 0.120 |
Why?
|
| Refraction, Ocular | 1 | 2016 | 188 | 0.120 |
Why?
|
| Eyeglasses | 1 | 2016 | 138 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 206 | 0.120 |
Why?
|
| Forecasting | 2 | 2014 | 2936 | 0.110 |
Why?
|
| Informed Consent | 1 | 2020 | 1010 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 935 | 0.110 |
Why?
|
| Decision Support Techniques | 3 | 2012 | 2006 | 0.110 |
Why?
|
| Stroke | 5 | 2014 | 9746 | 0.110 |
Why?
|
| Alginates | 1 | 2014 | 248 | 0.100 |
Why?
|
| Internship and Residency | 2 | 2014 | 5947 | 0.100 |
Why?
|
| Massachusetts | 3 | 2019 | 8890 | 0.100 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 1110 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 4054 | 0.100 |
Why?
|
| Polyesters | 1 | 2014 | 373 | 0.100 |
Why?
|
| Bandages | 1 | 2014 | 271 | 0.100 |
Why?
|
| Propensity Score | 4 | 2015 | 1971 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2015 | 714 | 0.100 |
Why?
|
| Diabetic Foot | 1 | 2016 | 382 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 1512 | 0.100 |
Why?
|
| Extremities | 2 | 2007 | 870 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2017 | 684 | 0.100 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 317 | 0.100 |
Why?
|
| beta Carotene | 1 | 2013 | 523 | 0.100 |
Why?
|
| Polyethylenes | 1 | 2014 | 294 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2016 | 1104 | 0.100 |
Why?
|
| Tibial Arteries | 3 | 2007 | 60 | 0.100 |
Why?
|
| Foundations | 1 | 2011 | 95 | 0.090 |
Why?
|
| Regional Blood Flow | 3 | 2017 | 1479 | 0.090 |
Why?
|
| Life Tables | 2 | 2012 | 367 | 0.090 |
Why?
|
| Graft Rejection | 4 | 2012 | 4498 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2015 | 9362 | 0.090 |
Why?
|
| Cohort Studies | 8 | 2023 | 41718 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 1429 | 0.090 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 403 | 0.090 |
Why?
|
| Graft Survival | 4 | 2012 | 3896 | 0.090 |
Why?
|
| Economic Competition | 1 | 2013 | 223 | 0.090 |
Why?
|
| Nursing | 1 | 2010 | 35 | 0.090 |
Why?
|
| Arteriosclerosis | 2 | 2008 | 1055 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 772 | 0.090 |
Why?
|
| Adult | 20 | 2019 | 223317 | 0.090 |
Why?
|
| Survival Rate | 6 | 2020 | 12823 | 0.090 |
Why?
|
| Blood Flow Velocity | 4 | 2022 | 1374 | 0.090 |
Why?
|
| Ophthalmic Solutions | 2 | 2009 | 312 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 20741 | 0.090 |
Why?
|
| Uveal Neoplasms | 1 | 2013 | 344 | 0.090 |
Why?
|
| Disease Progression | 3 | 2017 | 13646 | 0.090 |
Why?
|
| Patient Discharge | 2 | 2014 | 3467 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 585 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2012 | 580 | 0.090 |
Why?
|
| Cardiology | 2 | 2011 | 1701 | 0.080 |
Why?
|
| Treatment Failure | 3 | 2014 | 2658 | 0.080 |
Why?
|
| C-Reactive Protein | 3 | 2012 | 3851 | 0.080 |
Why?
|
| Retinitis Pigmentosa | 1 | 2013 | 395 | 0.080 |
Why?
|
| Societies, Medical | 3 | 2010 | 3964 | 0.080 |
Why?
|
| Probability | 2 | 2005 | 2476 | 0.080 |
Why?
|
| Iridectomy | 1 | 2009 | 48 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 806 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2016 | 1220 | 0.080 |
Why?
|
| Constriction | 1 | 2009 | 168 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 26325 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2012 | 1741 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 358 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 892 | 0.080 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5886 | 0.080 |
Why?
|
| Hospitals | 2 | 2013 | 3883 | 0.080 |
Why?
|
| Research Report | 1 | 2011 | 368 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2013 | 10092 | 0.070 |
Why?
|
| Drug Contamination | 1 | 2009 | 151 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 2 | 2007 | 463 | 0.070 |
Why?
|
| Curriculum | 2 | 2014 | 3786 | 0.070 |
Why?
|
| Blindness | 1 | 2012 | 585 | 0.070 |
Why?
|
| Thrombosis | 1 | 2022 | 2954 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2009 | 234 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1574 | 0.070 |
Why?
|
| Women | 1 | 2009 | 225 | 0.070 |
Why?
|
| Delirium | 1 | 2019 | 1698 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2005 | 96 | 0.070 |
Why?
|
| Cell Communication | 1 | 2014 | 1660 | 0.070 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 221 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2021 | 5345 | 0.070 |
Why?
|
| Equipment Design | 1 | 2015 | 3489 | 0.070 |
Why?
|
| Photoperiod | 1 | 2007 | 141 | 0.070 |
Why?
|
| Recurrence | 3 | 2016 | 8504 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2850 | 0.070 |
Why?
|
| Intraoperative Period | 1 | 2007 | 512 | 0.070 |
Why?
|
| Diagnostic Imaging | 3 | 2010 | 3530 | 0.060 |
Why?
|
| Lasers | 1 | 2010 | 951 | 0.060 |
Why?
|
| E2F Transcription Factors | 1 | 2006 | 270 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2017 | 10393 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2015 | 2505 | 0.060 |
Why?
|
| Anesthesia | 1 | 2016 | 1595 | 0.060 |
Why?
|
| Knee Joint | 1 | 2013 | 1683 | 0.060 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1135 | 0.060 |
Why?
|
| Vitamins | 1 | 2013 | 1639 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 540 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2014 | 2189 | 0.060 |
Why?
|
| Dementia | 1 | 2019 | 2741 | 0.060 |
Why?
|
| Myopia | 1 | 2007 | 254 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2024 | 2252 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 2 | 2013 | 1804 | 0.060 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2005 | 93 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 177 | 0.060 |
Why?
|
| Aneurysm, Infected | 1 | 2005 | 81 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2627 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2009 | 676 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2011 | 1126 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2016 | 6260 | 0.060 |
Why?
|
| Incidence | 5 | 2016 | 21526 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2007 | 418 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 2 | 2023 | 713 | 0.050 |
Why?
|
| Parturition | 1 | 2007 | 454 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2010 | 1064 | 0.050 |
Why?
|
| General Surgery | 1 | 2015 | 1720 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 843 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2745 | 0.050 |
Why?
|
| Ankle Brachial Index | 2 | 2016 | 163 | 0.050 |
Why?
|
| Vena Cava Filters | 1 | 2006 | 270 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2005 | 297 | 0.050 |
Why?
|
| Radiography | 2 | 2004 | 6975 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7121 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2005 | 252 | 0.050 |
Why?
|
| Sensory Deprivation | 1 | 2022 | 109 | 0.050 |
Why?
|
| Survivors | 1 | 2013 | 2381 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3370 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1368 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2002 | 177 | 0.050 |
Why?
|
| Endarterectomy | 1 | 2002 | 196 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4052 | 0.050 |
Why?
|
| Choroidal Neovascularization | 1 | 2005 | 364 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2429 | 0.050 |
Why?
|
| Seasons | 1 | 2007 | 1523 | 0.050 |
Why?
|
| Embolism | 1 | 2005 | 401 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 3249 | 0.050 |
Why?
|
| Aortic Rupture | 1 | 2004 | 322 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2016 | 15424 | 0.050 |
Why?
|
| Vision, Binocular | 1 | 2022 | 225 | 0.050 |
Why?
|
| Oligonucleotides | 3 | 2008 | 561 | 0.040 |
Why?
|
| Health Status | 1 | 2014 | 4091 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6844 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 7848 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3854 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 2 | 2017 | 1733 | 0.040 |
Why?
|
| Quality of Life | 4 | 2016 | 13485 | 0.040 |
Why?
|
| Inflammation Mediators | 3 | 2014 | 1889 | 0.040 |
Why?
|
| Ligation | 1 | 2021 | 446 | 0.040 |
Why?
|
| Lasers, Gas | 2 | 2012 | 104 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3928 | 0.040 |
Why?
|
| Intravitreal Injections | 2 | 2012 | 402 | 0.040 |
Why?
|
| Linear Models | 3 | 2014 | 5875 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2017 | 13048 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2005 | 863 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2011 | 8048 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2023 | 593 | 0.040 |
Why?
|
| Administration, Topical | 2 | 2014 | 703 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7236 | 0.040 |
Why?
|
| Electroretinography | 2 | 2013 | 524 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4401 | 0.040 |
Why?
|
| Heart Failure | 3 | 2014 | 11877 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6550 | 0.040 |
Why?
|
| Prevalence | 4 | 2019 | 15851 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 1493 | 0.040 |
Why?
|
| Cattle | 1 | 2023 | 3813 | 0.040 |
Why?
|
| Double-Blind Method | 5 | 2013 | 12451 | 0.030 |
Why?
|
| Radiology | 1 | 2010 | 2106 | 0.030 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 34 | 0.030 |
Why?
|
| Medical Errors | 1 | 2005 | 1260 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3418 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 520 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4306 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2017 | 215 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 405 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2006 | 1287 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2014 | 19 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2004 | 1680 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 3414 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 2144 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5702 | 0.030 |
Why?
|
| Sex Factors | 3 | 2017 | 10622 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2014 | 150 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10869 | 0.030 |
Why?
|
| Young Adult | 4 | 2014 | 59980 | 0.030 |
Why?
|
| North America | 2 | 2007 | 1287 | 0.030 |
Why?
|
| Chlorophyta | 1 | 2013 | 15 | 0.030 |
Why?
|
| Rats | 4 | 2012 | 23713 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7435 | 0.030 |
Why?
|
| Eye Enucleation | 1 | 2013 | 128 | 0.030 |
Why?
|
| Powders | 1 | 2013 | 78 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 220 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2014 | 4186 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1405 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 36582 | 0.030 |
Why?
|
| Texas | 1 | 2014 | 410 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 418 | 0.030 |
Why?
|
| Edema | 1 | 2017 | 764 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 951 | 0.030 |
Why?
|
| Elasticity | 2 | 2006 | 654 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 16036 | 0.030 |
Why?
|
| Guided Tissue Regeneration | 1 | 2013 | 86 | 0.030 |
Why?
|
| Oxygen | 1 | 2005 | 4252 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2007 | 2299 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2013 | 4026 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 454 | 0.030 |
Why?
|
| Dark Adaptation | 1 | 2013 | 224 | 0.030 |
Why?
|
| Blood Donors | 1 | 2014 | 343 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 513 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2007 | 4854 | 0.020 |
Why?
|
| Cardiovascular Agents | 2 | 2007 | 849 | 0.020 |
Why?
|
| Cost Savings | 1 | 2016 | 904 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 2227 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1337 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2013 | 255 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2013 | 5311 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 2337 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 1442 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 316 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2010 | 200 | 0.020 |
Why?
|
| New England | 1 | 2013 | 1058 | 0.020 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2009 | 34 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 711 | 0.020 |
Why?
|
| Vascular Diseases | 2 | 2010 | 1161 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 325 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 18330 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 4968 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 1377 | 0.020 |
Why?
|
| Iris | 1 | 2009 | 232 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 724 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14098 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2009 | 236 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2016 | 1965 | 0.020 |
Why?
|
| Prognosis | 3 | 2016 | 29963 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3618 | 0.020 |
Why?
|
| Ocular Hypertension | 1 | 2009 | 211 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Animals | 6 | 2023 | 168965 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2009 | 290 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 2764 | 0.020 |
Why?
|
| Light | 1 | 2013 | 1358 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2105 | 0.020 |
Why?
|
| Adiposity | 1 | 2017 | 1894 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 2276 | 0.020 |
Why?
|
| Hospitalization | 1 | 2006 | 10815 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2014 | 18989 | 0.020 |
Why?
|
| Visual Fields | 1 | 2013 | 1063 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2870 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 3621 | 0.020 |
Why?
|
| Cataract | 1 | 2012 | 837 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 2028 | 0.020 |
Why?
|
| Phenotype | 2 | 2014 | 16718 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 876 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2030 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2006 | 2078 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2006 | 203 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 2009 | 649 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 2478 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 2702 | 0.010 |
Why?
|
| Macular Degeneration | 1 | 2012 | 1015 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 2010 | 1086 | 0.010 |
Why?
|
| Benchmarking | 1 | 2010 | 1056 | 0.010 |
Why?
|
| Adolescent | 4 | 2014 | 89046 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2010 | 939 | 0.010 |
Why?
|
| Minority Groups | 1 | 2010 | 1214 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2744 | 0.010 |
Why?
|
| Hand | 1 | 2008 | 910 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 1549 | 0.010 |
Why?
|
| Research Design | 2 | 2009 | 6210 | 0.010 |
Why?
|
| Temperature | 1 | 2009 | 2232 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2004 | 239 | 0.010 |
Why?
|
| Time | 1 | 2004 | 551 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2012 | 1300 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 1243 | 0.010 |
Why?
|
| Glaucoma | 1 | 2012 | 1194 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2006 | 1824 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2011 | 1951 | 0.010 |
Why?
|
| Oximetry | 1 | 2005 | 462 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5796 | 0.010 |
Why?
|
| Medicare | 1 | 2019 | 6813 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 1916 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5329 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3322 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2010 | 2116 | 0.010 |
Why?
|
| Endocarditis | 1 | 2005 | 352 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 1430 | 0.010 |
Why?
|
| Child | 2 | 2022 | 80771 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 2002 | 381 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5785 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2012 | 3591 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4525 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4918 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3700 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2010 | 2519 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20169 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2350 | 0.010 |
Why?
|
| Medicaid | 1 | 2010 | 2836 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 4209 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 2954 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3934 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14766 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1905 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2009 | 5618 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2010 | 8531 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2002 | 1319 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 6000 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2005 | 1564 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8535 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8732 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 22254 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23621 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 18063 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 36485 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 42606 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 81912 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 15645 | 0.000 |
Why?
|